相关实验视频

Updated: Jun 28, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

在HER2-阳性局部先进乳腺癌中,Netrin-1染色和新辅助治疗反应之间的关系

Burcu Gülbağcı¹, Gözde Çakırsoy Çakar², Ahmet Küçükarda¹

¹Tekirdağ Dr Ismail Fehmi Cumalıoğlu State Hospital, Tekirdağ, Department of Medical Oncology, Tekirdağ, Turkey.

Cancer management and research

|February 19, 2026

概括

网林-1表达不能预测HER2阳性乳腺癌中新辅助治疗反应. 需要进一步的研究来探索Netrin-1在各种癌症中的治疗潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

网林-1,一种与拉米林相关的糖蛋白,影响胚胎发育和癌症进展.
乳腺癌中Netrin-1水平升高与晚期疾病和对治疗的耐药性相关.
了解Netrin-1的作用对于预测侵袭性癌症治疗结果至关重要.

研究的目的:

调查接受新辅助治疗的HER2阳性乳腺癌患者中Netrin-1表达和治疗反应之间的关联.
为了确定Netrin-1是否可以作为预测新辅助治疗疗效的生物标志物.

主要方法:

分析了90名HER2阳性乳腺癌患者的瘤组织,使用免疫组织化学来测试Netrin-1的表达.
根据染色比例和强度评估Netrin-1表达.
在具有不同Netrin-1表达水平的组之间比较病理治疗反应.

主要成果:

在Netrin-1表达 (比例或强度) 与新辅助治疗反应之间没有发现统计学上显著的关联.
虽然更高的Netrin-1表达显示出更频繁的Miller-Payne等级4-5的趋势,但这在统计学上并不显著.
基-67,激素受体状态和瘤尺寸被确定为病理完整反应的独立预测因素.

结论:

网林-1表达与HER2-阳性乳腺癌中新辅助治疗反应无关.
尽管在这个队列中缺乏关联,但Netrin-1的确定的生物功能需要进一步研究.
未来的研究应该探索Netrin-1在更广泛的恶性瘤中的预测和治疗潜力.

关键词:

阳性HER-2阳性的人.乳腺癌乳腺癌乳腺癌网-1 网-1 的使用方法

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

相关概念视频

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...